ITRMF
Iterum Therapeutics plcMarquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies 2× in & out | Q1 2025 | Q1 2026 | — | +0% |
| Two Sigma Investments | Q1 2025 | Q4 2025 | — | +0% |
| Citadel Advisors | Q1 2025 | Q2 2025 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Iterum Therapeutics plc. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Nov 20, 2025 — the most recent Form 4 on file — not from today.
- Form 40001193125-25-288848Nov 20, 2025
- Form 40000950170-25-106908Aug 12, 2025
- Form 40000950170-25-093872Jul 3, 2025
- Form 40000950170-25-008443Jan 23, 2025
- Form 40000950170-24-095096Aug 12, 2024
- Form 40000950170-24-095095Aug 12, 2024
- Form 40000950170-24-095094Aug 12, 2024
- Form 40001209191-23-059750Dec 27, 2023
- Form 40001209191-23-059133Dec 19, 2023
- Form 40001209191-23-057258Dec 4, 2023
- Form 40001209191-23-056685Nov 27, 2023
- Form 40001209191-23-056092Nov 20, 2023
- Form 40001209191-23-050912Oct 2, 2023
- Form 40001209191-23-050911Oct 2, 2023
- Form 40001209191-23-040406Jul 3, 2023
Fundamentals
XBRL · Iterum Therapeutics plcAnnual figures sourced directly from Iterum Therapeutics plc's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Iterum Therapeutics plc — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMar 31, 2026
- 8-KMaterial eventMar 27, 2026
- 8-KMaterial eventMar 3, 2026
- 8-KMaterial eventMar 2, 2026
- 8-KMaterial eventFeb 18, 2026
- DEF 14AProxy statementJan 2, 2026
- 8-KMaterial eventDec 12, 2025
- 10-QQuarterly reportNov 14, 2025
- 8-KMaterial eventNov 14, 2025
- 8-KMaterial eventOct 16, 2025
- 8-KMaterial eventSep 10, 2025
- 8-KMaterial eventAug 28, 2025
- 8-KMaterial eventAug 20, 2025
- 10-QQuarterly reportAug 5, 2025
- 8-KMaterial eventAug 5, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2025 | Q2 2025 | $0.00 | — | +0% |
| Two Sigma Investments | Q1 2025 | Q4 2025 | $0.00 | — | +0% |
| Renaissance Technologies | Q1 2025 | Q1 2026 | $0.00 | — | +0% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.